about
Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance?Oligodendrocytes: biology and pathologyMyelin dysfunction/degradation in the central nervous system: why are myelin sheaths susceptible to damage?Experimental models of neuromyelitis optica.Molecular pathogenesis of neuroinflammation.Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoproteinCell type-specific Nrf2 expression in multiple sclerosis lesions.Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS.The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitisDisease-specific molecular events in cortical multiple sclerosis lesions.Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SDIntrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive ratsMalignant melanoma in transgenic mice.Melanosis and associated tumors in transgenic mice.Clonal coat color variation due to a transforming gene expressed in melanocytes of transgenic mice.Progressive multiple sclerosis.Mosaic expression of a tyrosinase fusion gene in albino mice yields a heritable striped coat color pattern in transgenic homozygotesPain in neuromyelitis optica--prevalence, pathogenesis and therapy.T cell-activation in neuromyelitis optica lesions plays a role in their formation.Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.The shaping of the brain-specific T lymphocyte repertoire in the thymus.Immune control of the brain.Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination.Thymic stromal lymphopoietin is expressed in the intact central nervous system and upregulated in the myelin-degenerative central nervous system.Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.After injection into the striatum, in vitro-differentiated microglia- and bone marrow-derived dendritic cells can leave the central nervous system via the blood stream.The cholinergic anti-inflammatory system limits T cell infiltration into the neurodegenerative CNS, but cannot counteract complex CNS inflammation.Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions.Features of Human CD3+CD20+ T Cells.Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis.The susceptibility to experimental autoimmune encephalomyelitis is not related to dysferlin-deficiency.Prospects of transcript profiling for mRNAs and MicroRNAs using formalin-fixed and paraffin-embedded dissected autoptic multiple sclerosis lesions.Animal models of demyelination.Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous system.Autoimmune CD4+ T cell memory: lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires.Transgenic Lewis rats overexpressing the proteolipid protein gene: myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis.Multiple sclerosis and Alzheimer's diseaseSelective and antigen-dependent effects of myelin degeneration on central nervous system inflammationEndoplasmic reticulum stress in PLP-overexpressing transgenic rats: gray matter oligodendrocytes are more vulnerable than white matter oligodendrocytes
P50
Q28294973-3B12D0AA-E80B-40F1-84CC-B01AC82B28B7Q30051584-B43CFC3B-4FD1-43F4-9EDF-4F34BB7738F7Q33639831-1F4959C1-E257-4456-BBEE-87FF0C1AED90Q33785380-DF61D243-590F-4AA9-8502-D44527BB964DQ35564938-FA0D0615-7CC2-4B71-8D43-B8CA59402F92Q35818687-2967131C-14B6-4AF3-9B2B-517F654FEF7AQ35856138-105C60AE-A1FD-408E-8648-972F4EFFC5C2Q36303835-35CFB5F0-AFD3-45F2-B306-18D8A48EA089Q36399022-B6E1968D-2AB6-4D7A-8885-B174E17E8655Q36904909-2E964E20-1456-44E7-BEAF-88222E3B392FQ37160320-8078812D-340A-4B22-A4CA-EE8A73A2FEA0Q37180238-E1ECF202-4BEB-4D8F-BC57-D6CD9F4F8304Q37361700-1F0EE6AE-EF3B-400D-A54F-C513DFB0694EQ37361801-C21C3C64-47C3-4604-BD2A-4E315C993F91Q37555738-3080519F-0568-460C-AFC3-F2C364F467D1Q37591982-99295A81-D5F6-48AD-BF7B-019C4FB8DE21Q37611843-B9CF13AC-05A3-4D15-BFD1-6D0008920EEBQ38235026-470BE003-FAA9-4C05-900D-56509184F8A3Q39039987-AA9891B8-8CE7-40D4-B468-4BECBFFB01F6Q39770767-C0CC23FD-EA85-4510-AD1E-19688641E94CQ41230479-C4DB1CA0-43DA-4328-ACEA-56AA9282B684Q41293460-49B47850-22CE-4D07-AF1F-5869B1FAA8CDQ41475832-941258A2-E660-4224-A139-ABF2805D8127Q42237681-14C8B309-E2D1-4643-BB1F-C82EA482269FQ42260800-99EB9F97-5DEA-4E65-B716-999FD6E1395EQ43198620-8BDCF3FA-2559-428B-803F-3A96FD817336Q46062250-96D50EAD-D0A5-4F0B-8D7F-6E6998379270Q47186070-BC398D0E-704E-400E-9C74-EF37C0670F9BQ48161422-35FF2D51-E64B-472D-8A9F-93E00D84FBA4Q48427400-909E388B-2D1F-4959-AB66-0807010C00BBQ48527008-CBAB9647-2E41-4F99-B318-5CCD3179F87AQ48695970-E480415A-B2BF-4975-8173-304B87A9A756Q48719321-8B32D4E0-69BE-4490-B3C1-3712F422EA20Q48972525-01B340D4-6AED-4706-91A3-2207476B911EQ50664397-F7A5D9C7-040F-4D62-B873-529343402454Q50764004-BF72F467-93BD-492D-AB7C-1503A30129FDQ52176328-6D117A37-4A3E-47D9-8DE9-9F7487F9FF86Q61709524-4AA55B72-5261-472C-B936-4D3E62B697CCQ61709613-E3FED7F7-D7F8-485B-A92C-DEED3A960887Q61709661-AFC82C5E-D418-4953-8A62-CA10979A0E99
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Monika Bradl
@ast
Monika Bradl
@en
Monika Bradl
@es
Monika Bradl
@nl
Monika Bradl
@sl
type
label
Monika Bradl
@ast
Monika Bradl
@en
Monika Bradl
@es
Monika Bradl
@nl
Monika Bradl
@sl
prefLabel
Monika Bradl
@ast
Monika Bradl
@en
Monika Bradl
@es
Monika Bradl
@nl
Monika Bradl
@sl
P106
P21
P31
P496
0000-0003-2239-1586
P569
2000-01-01T00:00:00Z